Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AbstractB cell fate is determined by the strength of signals from the antigen receptor and from co‐receptors that adjust the activation threshold and tune the B cell to its environment. These co‐receptors have been broadly classified into inhibitory and enhancing groups, yet some, such as CD22, may have dual effects. CD22 recruits a variety of signal enhancers at the same time as Lyn‐dependent phosphorylation leads to the binding of the inhibitory phosphatase SHP‐1. To assess the relative importance of Lyn‐ and CD22‐dependent and ‐independent pathways, we generated Lyn and CD22 single‐deficient mice and Lyn/CD22 double‐deficient mice expressing the MD4 immunoglobulin transgene against hen egg lysozyme (IgHEL). This genetic approach has enabled us to compare the contributions of Lyn and CD22 to B cell development in vivo, independent of BCR specificity and in the presence and absence of self‐antigen. Our results show that although the effects of Lyn are dominant in negative regulation of B cell hyperactivity, Lyn and CD22 have independent and additive effects on B cell survival. These findings emphasize the subtle nature of regulation at the BCR and the usefulness of genetic complementation to dissect common and parallel pathways.

Original publication

DOI

10.1002/eji.200535247

Type

Journal article

Journal

European Journal of Immunology

Publisher

Wiley

Publication Date

12/2005

Volume

35

Pages

3655 - 3663